Hepatitis

Affordable generic versions from China could save millions of people’s lives Médecins Sans Frontières (MSF) today filed a legal patent challenge at China’s State Intellectual Property Office (SIPO), requesting the invalidation of the patent granted to US pharmaceutical corporation Gilead Sciences...
Turn into this narrow side street from a traffic-choked avenue in Phnom Penh, the capital of Cambodia, and the volume suddenly drops. Removed from the honking tuk-tuks and bathing in shade, a bright mural welcomes visitors to the drop-in centre of a charity, called ‘Mith Samlanh’. Meaning ‘close...
Gilead recently launched one of these drugs for $100/pill in China Médecins Sans Frontières (MSF) has filed a legal patent challenge in China against US pharmaceutical corporation Gilead’s patent application for the combination of two crucial oral hepatitis C medicines, sofosbuvir and velpatasvir...
Dramatic price drops should allow countries to provide treatment for millions of people On the eve of the World Hepatitis Summit in Sao Paolo, the international medical humanitarian organization Médecins Sans Frontières (MSF) today announced that it had secured deals for generic hepatitis C...
American medical doctor Theresa Chan is in Cambodia, based in MSF's hepatitis clinic in Phnom Penh.
After Phuong was diagnosed with Hepatitis C by a doctor in Vietnam, she was given some vitamins for her liver. Accompanying the pills was the advice that nothing much more could be done for her in there or in her native Cambodia. That was five years ago. Today the 58-year-old grandmother is hoping...
Two years since the first signs of the West Africa Ebola outbreak, the world today is little more prepared to respond to such an emergency than it was then, warns international humanitarian aid organisation Médecins Sans Frontières (MSF), while the lack of R&D into needed medicines and...
Indian generic companies should reject Gilead’s controversial hepatitis C programme Programme could compromise patient treatment and privacy rights Ahead of a meeting in Jaipur, India this week between US pharmaceutical company Gilead Sciences and several Indian companies which have entered into an...
An epidemic of hepatitis E is escalating across refugee camps in Maban County, South Sudan. So far MSF has treated 3991 patients in its health facilities in the camps and has recorded 88 deaths, including 15 pregnant women. Hepatitis E is a virus that causes liver disease and can lead to acute...
Subscribe to RSS - Hepatitis